Lung Fung Group Holdings Limited

Lung Fung Group Holdings Limited

2290.HK
Lung Fung Group Holdings LimitedHK flagHong Kong Stock Exchange
3.51
HKD
-0.09
- -
1.76BMarket Cap
2023 Y
2024 Y
2025 Y
Revenue per Share
2.19
4.04
4.92
Basic EPS, GAAP
-0.05
0.29
0.34
Free Cash Flow per Basic Share
1.41
2.42
2.82
Dividend per Share
- -
- -
- -
Book Value per Share
-0.03
0.26
0.09
Tangible Book Value per Share
-0.03
0.26
0.09
Basic Weighted Avg Shares
500
500
500
Sales/Revenue/Turnover
1,094
2,021
2,460
Operating Margin (%)
1.16
12.01
12.89
Depreciation Expense
128
134
174
Net Income, GAAP
-27
145
170
Effective Tax Rate (%)
- -
20.08
21.83
Profit Margin (%)
-2.48
7.15
6.93
Working Capital
-794
-674
-644
LT Debt
92
115
130
Total Equity
-15
130
44
Return on Invested Capital (%)
- -
18.02
22.19
Return on Capital (%)
- -
17.39
19.07
Return on Common Equity (%)
- -
- -
196.31

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-65.73%
Free Cash Flow
- -
- -
16.53%
Net Income, GAAP
- -
- -
17.92%
Sales/Revenue/Turnover
- -
- -
21.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
2,021
2025
- -
- -
- -
- -
2,460
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.29
2025
- -
- -
- -
- -
0.34
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Siu Hoi Tse
Full Time Employees
694
Sector
Healthcare
Industry
Medical - Distribution
Address
5/F, Lung Fung Group Centre Fanling NT Hong Kong
IPO Date
Jun 5, 2026
Business
Lung Fung Group Holdings Limited is an Hong Kong-based investment holding company that operates as a diversified retailer focused on health, beauty, pharmaceutical, and related consumer products. The company designs, sources, and distributes a broad range of merchandise through a network of retail stores and online platforms under its Lung Fung brand and related channels. It focuses on products spanning traditional Chinese medicines, Western medicines, health supplements, skincare and cosmetic products, fragrances, personal care items, maternal and infant goods, food, pet food, and various household daily necessities, catering to a broad consumer base in Hong Kong and regional markets. Latest major company changes include ongoing expansion of its retail footprint in Hong Kong with additional stores and the introduction of new product categories to attract a younger demographic, as well as strategic discussions around potential listings and corporate reorganizations to support growth; the company also reports expanding supplier relationships and logistics capabilities to support SKU diversification and inventory management. The firm actively pursues partnerships and collaborations to enhance its pharmacy focus and to broaden the scope of consumer goods offered in its stores, reflecting a strategic shift toward a more expansive omnichannel model and deeper penetration into health and beauty segments. Industry and business segments: retail of beauty products, health products, and pharmaceuticals; wholesale supply of pharmaceutical, health and beauty products and other consumer goods. Target markets: general consumer population in Hong Kong and nearby regions, with procurement from a broad supplier base worldwide. Geographic operations: primarily Hong Kong, with potential cross-border sourcing and distribution in the Greater China region. Founding year and headquarters: established in 1990s with headquarters in Hong Kong; operates as part of a larger corporate group through subsidiary and affiliated entities. Subsidiaries and parent relationships: operates via Lung Fung Group subsidiaries; part of the broader TTK Holding Limited corporate family, with governance and financing channels aligned to group-wide strategies.